Angela Fan: Persistent Unmet Needs in Polycythemia Vera
Angela Fan, Lead Health Economics and Outcomes Research in Oncology, shared a post on LinkedIn about a recent article by Aaron T Gerds et al., published in Journal of Blood Medicine, adding:
“Pleased to share that our US retrospective real-world evidence study, Disease Burden, Inadequate Hematocrit Control, and Thromboembolic Events in Patients with Polycythemia Vera Despite Current Standard of Care Treatment, was recently published in the Journal of Blood Medicine.
This study adds important peer-reviewed real-world evidence highlighting the persistent unmet needs and disease burden among patients with polycythemia vera (PV) despite current standard-of-care treatment.
The findings demonstrate that many treated patients continue to experience challenges achieving adequate hematocrit control and remain at risk for thromboembolic events in routine clinical practice.
The study further highlights the substantial clinical and economic burden of thromboembolic events, providing additional insight into PV‘s ongoing impact on patients and the healthcare system.
Congratulations to all of the authors on this important publication, and special thanks to Dr. Aaron Gerds, for his collaboration and contributions to this work.”
Title: Disease Burden, Inadequate Hematocrit Control, and Thromboembolic Events in Patients with Polycythemia Vera Despite Current Standard of Care Treatment: A Retrospective Claims Study
Authors: Aaron T Gerds, Qi Fan, Michelle Jerry, Alicia Cerretani, Anh Thu Tran, Luis Hernandez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI